癌变·畸变·突变 ›› 2003, Vol. 15 ›› Issue (1): 32-34.doi: 10.3969/j.issn.1004-616x.2003.01.009

• 检测研究 • 上一篇    下一篇

放射增效剂Ⅱ号致突变性研究

刘晓秋1, 王荣先1, 田庆伟2   

  1. 1. 中国医学科学院中国协和医科大学放射医学研究所临床室, 天津 300192; 2. 天津医科大学公共卫生学院卫生毒理学教研室, 天津 300070
  • 收稿日期:2002-05-31 修回日期:2002-07-22 出版日期:2003-01-30 发布日期:2003-01-30
  • 通讯作者: 刘晓秋

MUTAGENICITY RESEARCH OF No.Ⅱ DRUG

LIU Xiao-qiu, WANG Rong-xian, TIAN Qing-wei   

  1. Institute of Radiation Medicine Chinese Academy of Medical Sciences, Tianjin 300192 , China
  • Received:2002-05-31 Revised:2002-07-22 Online:2003-01-30 Published:2003-01-30
  • Contact: LIU Xiao-qiu

摘要: 目的与方法: 用Ames 试验、 CHO-K细胞染色体畸变试验及微核试验对Ⅱ号药进行了致突变性研究。 结果: Ames 试验在1~5 000 μg / 皿剂量范围内加与不加S 9条件下,4个菌株的回变菌落数均未有2倍以上的增加;微核试验显示在25~125 mg / kg剂量,小鼠骨髓嗜多染红细胞微核细胞率(MNCF)与对照组比较无显著性差异(P>0.05);CHO-K细胞染色体畸变试验显示在不加S 9条件下,31~250 μg / ml剂量范围内染色体畸变率小于5 %, 在加S 9条件下250 μg / ml剂量组畸变率为8 %, 属可疑阳性。 结论: Ames 试验和微核试验均为阴性,在高剂量组加S 9条件下,染色体畸变率为可疑阳性,表明在高剂量条件下,Ⅱ号药对体细胞有可疑遗传毒性。

关键词: Ames试验, 微核, 染色体畸变, Ⅱ号药

Abstract: Purpose and methods: The mutagenicity of No.Ⅱdrug was examined using Ames test, CHO-K cell chromosome aberration test and micronucleus test. Results: No.Ⅱ drug in the dose range of 1~5 000 μg / plate did not increase the number of reversion mutation in any of the 4 strains with or without S 9 in Ames test. The frequencies of micronuclear cell(MNCF) in PCE did not increase with dose of 25~125 mg / kg in micronucleus test. In CHO-K cell chromosome aberration test, the result was suspiciously positive because the frequency of chromosome aberration increased to 8 % with the dose of 250 μg / ml with S 9. Conclusion: The results of No.Ⅱ drug in Ames test and micronucleus test were negative, and at higher dose in chromosome aberration test the result was suspiciously positive.

Key words: No.Ⅱ drug, Ames test, Micronucleus, Chromosome aberration